Schizophrenia News and Research

Latest Schizophrenia News and Research

Oxytocin shows evidence of therapeutic value for autism, schizophrenia

The hormone oxytocin could play a role in treating psychiatric disorders such as autism and schizophrenia, according to a review article in the September Harvard Review of Psychiatry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

17 Sep 2013

‘Risk circuits’ for schizophrenia refined

A study sheds further light on the brain circuits that may underlie risk for schizophrenia.

16 Sep 2013

Adolescent emotion unravels social impact of psychotic symptoms

Emotional or behavioral problems may explain why some adolescents with psychotic symptoms find it hard to interact socially, researchers highlight.

12 Sep 2013

Omeros announces positive data from OMS824 Phase 1 clinical trial

Omeros Corporation today announced positive data from the Company's Phase 1 clinical trial evaluating the pharmacokinetics of OMS824, the lead compound in Omeros' phosphodiesterase 10 program, further supporting that OMS824 can achieve superior target engagement with lesser side effects compared to other PDE10 inhibitors in development.

12 Sep 2013

Psychiatrist documents how schizophrenia impacts brain tissue

It's hard to fully understand a mental disease like schizophrenia without peering into the human brain. Now, a study by University of Iowa psychiatry professor Nancy Andreasen uses brain scans to document how schizophrenia impacts brain tissue as well as the effects of anti-psychotic drugs on those who have relapses.

12 Sep 2013

Research suggests possibility of using cell transplants to treat schizophrenia

Research from the School of Medicine at The University of Texas Health Science Center at San Antonio suggests the exciting possibility of using cell transplants to treat schizophrenia.

10 Sep 2013

Scientists find link between early-onset Parkinson's and 22q11.2 deletion syndrome

Scientists at the Centre for Addiction and Mental Health (CAMH) and University Health Network (UHN) have found a new link between early-onset Parkinson's disease and a piece of DNA missing from chromosome 22. The findings help shed new light on the molecular changes that lead to Parkinson's disease.

10 Sep 2013

Plasma marker inflames schizophrenia risk

Elevated plasma levels of the inflammatory molecule C-reactive protein may be a marker of an increased risk for developing schizophrenia, a study suggests.

6 Sep 2013

Negative symptom clue to smoking in schizophrenia patients

Patients with schizophrenia may have a preponderance to cigarette smoking because it reduces negative symptom severity, researchers report.

5 Sep 2013

Longer looks: Phenomenal growth of the Cleveland Clinic prompts hopes for the city; the bittersweet decision to donate organs

Delos M. "Toby" Cosgrove arrived at the Cleveland Clinic in 1975 as an "incredibly poor" 34-year-old dreaming of a life as a cardiac surgeon. … As the years passed he became well-known for pioneering the replacement of heart valves, eventually assuming the chair of the department of cardiothoracic surgery.

From Medtronic 5 Sep 2013

Dopamine improves deficiencies in social behavior, could have implications for neuropsychiatric disorders

A stressful pregnancy might be the last thing a future mother needs, but it is to her unborn baby that this stress spells real trouble. All because stress hormones (called glucocorticoids or GCs) can disturb normal foetal brain development, leading to behavioural and/or emotional problems later in life.

5 Sep 2013

Tel Aviv University researchers use zoological methods to study people with serious mental disorders

Because animals can't talk, researchers need to study their behavior patterns to make sense of their activities. Now researchers at Tel Aviv University are using these zoological methods to study people with serious mental disorders.

5 Sep 2013

Increased mortality in schizophrenia ‘not attributable to drug therapy’

The increased mortality risk observed among patients with severe psychiatric illness, including schizophrenia, does not seem to be attributable to use of psychopharmacologic therapy, study findings indicate.

4 Sep 2013

Research finding provides blueprint for understanding how the brain communicates with itself

During a normal conversation, your brain is constantly adjusting the volume to soften the sound of your own voice and boost the voices of others in the room.

4 Sep 2013

Genetic score backs schizophrenia spectrum

Researchers report that polygenic scores derived from one well-characterized cohort of schizophrenia patients correspond to clinical diagnostic categories in another.

3 Sep 2013

Researchers identify potential drug target to recover from jet lag, disruptions in circadian system

University of Notre Dame researchers, as part of a collaborative effort, have identified a protein that potentially could be a target for drugs that would help people recover faster from jet lag and better adjust their circadian rhythms during rotational shift work.

31 Aug 2013

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Schizophrenia is one of the most devastating neurological conditions, with only 30 percent of sufferers ever experiencing full recovery. While current medications can control most psychotic symptoms, their side effects can leave individuals so severely impaired that the disease ranks among the top ten causes of disability in developed countries.

31 Aug 2013

Schizophrenia genetics come into focus

A study in Nature Genetics illustrates the large impact of genetic variation on risk for schizophrenia.

30 Aug 2013

Potential drug target to treat depression and other mood disorders may lie in GABA neurons

A new drug target to treat depression and other mood disorders may lie in a group of GABA neurons (gamma-aminobutyric acid -the neurotransmitters which inhibit other cells) shown to contribute to symptoms like social withdrawal and increased anxiety, Penn Medicine researchers report in a new study in the Journal of Neuroscience.

30 Aug 2013

Heritability of severe mental illness may be underestimated

Around one in three children of parents with a severe mental illness – schizophrenia, bipolar disorder, or major depressive disorder – will develop such a disorder themselves by early adulthood, a meta-analysis has found.

29 Aug 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Oxytocin shows evidence of therapeutic value for autism, schizophrenia

‘Risk circuits’ for schizophrenia refined

Adolescent emotion unravels social impact of psychotic symptoms

Omeros announces positive data from OMS824 Phase 1 clinical trial

Psychiatrist documents how schizophrenia impacts brain tissue

Research suggests possibility of using cell transplants to treat schizophrenia

Scientists find link between early-onset Parkinson's and 22q11.2 deletion syndrome

Plasma marker inflames schizophrenia risk

Negative symptom clue to smoking in schizophrenia patients

Longer looks: Phenomenal growth of the Cleveland Clinic prompts hopes for the city; the bittersweet decision to donate organs

Dopamine improves deficiencies in social behavior, could have implications for neuropsychiatric disorders

Tel Aviv University researchers use zoological methods to study people with serious mental disorders

Increased mortality in schizophrenia ‘not attributable to drug therapy’

Research finding provides blueprint for understanding how the brain communicates with itself

Genetic score backs schizophrenia spectrum

Researchers identify potential drug target to recover from jet lag, disruptions in circadian system

Researchers develop model that completes bridge between cellular and human studies of schizophrenia

Schizophrenia genetics come into focus

Potential drug target to treat depression and other mood disorders may lie in GABA neurons

Heritability of severe mental illness may be underestimated

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Schizophrenia News and Research

Latest Schizophrenia News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in